- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/50 - Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
Patent holdings for IPC class A61K 38/50
Total number of patents in this class: 644
10-year publication summary
|
53
|
37
|
56
|
68
|
65
|
68
|
81
|
52
|
43
|
30
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theriva Biologics, Inc. | 83 |
44 |
| President and Fellows of Harvard College | 5952 |
17 |
| Icahn School of Medicine at Mount Sinai | 936 |
16 |
| Polaris Group | 19 |
16 |
| Erytech Pharma | 68 |
14 |
| Jazz Pharmaceuticals Ireland Limited | 142 |
13 |
| Beam Therapeutics Inc. | 232 |
13 |
| University of Massachusetts | 2222 |
12 |
| The Regents of the University of California | 19839 |
10 |
| The Trustees of the University of Pennsylvania | 4315 |
9 |
| Thornhill Therapeutics, Inc. | 28 |
9 |
| California Institute of Technology | 3969 |
8 |
| AERase, Inc. | 18 |
8 |
| Synthetic Biologics, Inc. | 31 |
8 |
| Dana-Farber Cancer Institute, Inc. | 2556 |
7 |
| Kyon Biotech AG | 19 |
7 |
| The Rockefeller University | 567 |
7 |
| Translate bio, Inc. | 415 |
7 |
| Rowan University | 172 |
6 |
| The Trustees of Indiana University | 726 |
6 |
| Other owners | 407 |